Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 17, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval for Apremilast Tablets, 10 mg, 20 mg and 30 mg".
Glenmark Pharmaceuticals Limited Press Release Oct 17 2023
Filed with NSE · · 2 pages · English
Release
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Oct 12 2023
- Press Release Sep 27 2023
- Press Release Sep 21 2023
- Press Release Aug 17 2023
- Press Release Aug 01 2023
Later from Glenmark Pharmaceuticals
- Press Release Oct 18 2023
- Glenmark Pharmaceuticals Limited Press Release Nov 07 2023
- Press Release Nov 10 2023
- Glenmark Pharmaceuticals Limited Press Release Jan 03 2024
- Glenmark Pharmaceuticals Limited Press Release Jan 25 2024
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals